{"protocolSection": {"identificationModule": {"nctId": "NCT00588406", "orgStudyIdInfo": {"id": "07.02.019"}, "organization": {"fullName": "Northwell Health", "class": "OTHER"}, "briefTitle": "Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.", "officialTitle": "Emergency Department (ED) Use of Nebulized Budesonide as an Adjunct to Standardized Therapy in Acutely Ill Adults With Refractory Asthma: a Randomized, Double-blinded, Placebo-controlled Trial"}, "statusModule": {"statusVerifiedDate": "2015-12", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2007-09"}, "primaryCompletionDateStruct": {"date": "2009-12", "type": "ACTUAL"}, "completionDateStruct": {"date": "2009-12", "type": "ACTUAL"}, "studyFirstSubmitDate": "2007-12-21", "studyFirstSubmitQcDate": "2007-12-21", "studyFirstPostDateStruct": {"date": "2008-01-08", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2015-10-12", "resultsFirstSubmitQcDate": "2015-12-15", "resultsFirstPostDateStruct": {"date": "2016-01-21", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2015-12-15", "lastUpdatePostDateStruct": {"date": "2016-01-21", "type": "ESTIMATED"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "PRINCIPAL_INVESTIGATOR", "investigatorFullName": "Robert A Silverman", "investigatorTitle": "Physician", "investigatorAffiliation": "Northwell Health"}, "leadSponsor": {"name": "Northwell Health", "class": "OTHER"}, "collaborators": [{"name": "AstraZeneca", "class": "INDUSTRY"}, {"name": "Jacobi Medical Center", "class": "OTHER"}, {"name": "Nassau University Medical Center", "class": "OTHER"}]}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "To determine whether adding nebulized inhaled steroids to the standard care of acutely ill ED patients with refractory acute asthma helps improve forced expiratory volume at one second (FEV1) and decrease the need for hospitalization.", "detailedDescription": "This is a randomized clinical trial studying the effect of nebulized budesonide (Pulmicort) in acutely ill adults presenting to the Emergency Department with severe asthma. Budesonide is an inhaled steroid FDA approved for the treatment of pediatric chronic asthma. ED entry criteria include hyporesponsiveness to nebulized beta-agonists and an FEV1\\<50% predicted. The trial will evaluate the efficacy of multiple doses of nebulized budesonide as an adjunct to a highly regimented standardized treatment protocol; standard care consists of bronchodilators (beta-agonists/anticholinergics), systemic steroids, and intravenous magnesium sulfate (if the FEV1\\<25% predicted). The primary efficacy endpoint will be the FEV1 4 hours after administration of the study intervention. An additional safety and efficacy endpoint will take place at 5 hours after study intervention. The treatments will be coupled with a protocol-defined assessment regimen, with endpoints measured before each treatment and on ED disposition (at 5 hours after study intervention)."}, "conditionsModule": {"conditions": ["Asthma"], "keywords": ["acute, emergency department"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE3"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "TRIPLE", "whoMasked": ["PARTICIPANT", "CARE_PROVIDER", "INVESTIGATOR"]}}, "enrollmentInfo": {"count": 95, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "B", "type": "EXPERIMENTAL", "description": "Budesonide, 2mg, 4 doses, plus standard care", "interventionNames": ["Drug: Budesonide", "Drug: albuterol", "Drug: Ipratropium bromide", "Drug: Prednisone"]}, {"label": "P", "type": "PLACEBO_COMPARATOR", "description": "Placebo plus standard care", "interventionNames": ["Drug: albuterol", "Drug: Ipratropium bromide", "Drug: Prednisone"]}], "interventions": [{"type": "DRUG", "name": "Budesonide", "description": "2mg/dose by nebulizer, four doses over 3 hours", "armGroupLabels": ["B"], "otherNames": ["Pulmicort Respules"]}, {"type": "DRUG", "name": "albuterol", "description": "2.5mg/dose by nebulizer, 7 doses over 6 hours", "armGroupLabels": ["B", "P"], "otherNames": ["proventil", "proair", "ventolin", "salbutamol"]}, {"type": "DRUG", "name": "Ipratropium bromide", "description": "2.5 mg, one dose", "armGroupLabels": ["B", "P"], "otherNames": ["Atrovent"]}, {"type": "DRUG", "name": "Prednisone", "description": "60mg PO", "armGroupLabels": ["B", "P"], "otherNames": ["deltasone"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "FEV1 Percent Predicted", "timeFrame": "4 hours post-randomization"}], "secondaryOutcomes": [{"measure": "Hospitalization", "timeFrame": "6 hours"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* FEV1\\<50% predicted after bronchodilator therapy, age 18-60, presenting to an emergency department with acute asthma\n\nExclusion Criteria:\n\n* other chronic lung disease, \\>15 pack years smoking", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "maximumAge": "60 Years", "stdAges": ["ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Robert Silverman, MD", "affiliation": "Northwell Health", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Jacobi Medical Center", "city": "Bronx", "state": "New York", "zip": "10461", "country": "United States", "geoPoint": {"lat": 40.84985, "lon": -73.86641}}, {"facility": "Nassau University Medical Center", "city": "East Meadow", "state": "New York", "zip": "11554", "country": "United States", "geoPoint": {"lat": 40.71399, "lon": -73.55902}}, {"facility": "Long Island Jewish Medical Center", "city": "Queens", "state": "New York", "zip": "11042", "country": "United States", "geoPoint": {"lat": 40.68149, "lon": -73.83652}}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Budesonide", "description": "Budesonide, 2mg, 4 doses, plus standard care\n\nBudesonide: 2mg/dose by nebulizer, four doses over 3 hours\n\nalbuterol: 2.5mg/dose by nebulizer, 7 doses over 6 hours\n\nIpratropium bromide: 2.5 mg, one dose\n\nPrednisone: 60mg PO"}, {"id": "FG001", "title": "Placob", "description": "Placebo plus standard care\n\nalbuterol: 2.5mg/dose by nebulizer, 7 doses over 6 hours\n\nIpratropium bromide: 2.5 mg, one dose\n\nPrednisone: 60mg PO"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "46"}, {"groupId": "FG001", "numSubjects": "49"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "46"}, {"groupId": "FG001", "numSubjects": "49"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Budesonide", "description": "Budesonide, 2mg, 4 doses, plus standard care\n\nBudesonide: 2mg/dose by nebulizer, four doses over 3 hours\n\nalbuterol: 2.5mg/dose by nebulizer, 7 doses over 6 hours\n\nIpratropium bromide: 2.5 mg, one dose\n\nPrednisone: 60mg PO"}, {"id": "BG001", "title": "Placebo", "description": "Placebo plus standard care\n\nalbuterol: 2.5mg/dose by nebulizer, 7 doses over 6 hours\n\nIpratropium bromide: 2.5 mg, one dose\n\nPrednisone: 60mg PO"}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "46"}, {"groupId": "BG001", "value": "49"}, {"groupId": "BG002", "value": "95"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "37.2", "spread": "11.4"}, {"groupId": "BG001", "value": "42.6", "spread": "11.4"}, {"groupId": "BG002", "value": "40", "spread": "11.7"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "29"}, {"groupId": "BG001", "value": "22"}, {"groupId": "BG002", "value": "51"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "17"}, {"groupId": "BG001", "value": "27"}, {"groupId": "BG002", "value": "44"}]}]}]}, {"title": "Race/Ethnicity, Customized", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "White", "categories": [{"measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "3"}, {"groupId": "BG002", "value": "5"}]}]}, {"title": "Black", "categories": [{"measurements": [{"groupId": "BG000", "value": "28"}, {"groupId": "BG001", "value": "18"}, {"groupId": "BG002", "value": "46"}]}]}, {"title": "Hispanic", "categories": [{"measurements": [{"groupId": "BG000", "value": "12"}, {"groupId": "BG001", "value": "20"}, {"groupId": "BG002", "value": "32"}]}]}, {"title": "Other", "categories": [{"measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "6"}, {"groupId": "BG002", "value": "8"}]}]}, {"title": "Unknown", "categories": [{"measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "2"}, {"groupId": "BG002", "value": "4"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "46"}, {"groupId": "BG001", "value": "49"}, {"groupId": "BG002", "value": "95"}]}]}]}, {"title": "Forced expiratory volume at one second (FEV1) % predicted", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "percent predicted of FEV1", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "29.5", "spread": "9.5"}, {"groupId": "BG001", "value": "29", "spread": "8.1"}, {"groupId": "BG002", "value": "29.2", "spread": "8.7"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "FEV1 Percent Predicted", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percent predicted of FEV1", "timeFrame": "4 hours post-randomization", "groups": [{"id": "OG000", "title": "Budesonide", "description": "Budesonide, 2mg, 4 doses, plus standard care\n\nBudesonide: 2mg/dose by nebulizer, four doses over 3 hours\n\nalbuterol: 2.5mg/dose by nebulizer, 7 doses over 6 hours\n\nIpratropium bromide: 2.5 mg, one dose\n\nPrednisone: 60mg PO"}, {"id": "OG001", "title": "Placebo", "description": "Placebo plus standard care\n\nalbuterol: 2.5mg/dose by nebulizer, 7 doses over 6 hours\n\nIpratropium bromide: 2.5 mg, one dose\n\nPrednisone: 60mg PO"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "46"}, {"groupId": "OG001", "value": "49"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "51.7", "spread": "16.8"}, {"groupId": "OG001", "value": "52.6", "spread": "15.8"}]}]}]}, {"type": "SECONDARY", "title": "Hospitalization", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage of participants", "timeFrame": "6 hours", "groups": [{"id": "OG000", "title": "Budesonide", "description": "Budesonide, 2mg, 4 doses, plus standard care\n\nBudesonide: 2mg/dose by nebulizer, four doses over 3 hours\n\nalbuterol: 2.5mg/dose by nebulizer, 7 doses over 6 hours\n\nIpratropium bromide: 2.5 mg, one dose\n\nPrednisone: 60mg PO"}, {"id": "OG001", "title": "Placebo", "description": "Placebo plus standard care\n\nalbuterol: 2.5mg/dose by nebulizer, 7 doses over 6 hours\n\nIpratropium bromide: 2.5 mg, one dose\n\nPrednisone: 60mg PO"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "46"}, {"groupId": "OG001", "value": "49"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "39"}, {"groupId": "OG001", "value": "39"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "eventGroups": [{"id": "EG000", "title": "Budesonide", "description": "Budesonide, 2mg, 4 doses, plus standard care\n\nBudesonide: 2mg/dose by nebulizer, four doses over 3 hours\n\nalbuterol: 2.5mg/dose by nebulizer, 7 doses over 6 hours\n\nIpratropium bromide: 2.5 mg, one dose\n\nPrednisone: 60mg PO", "seriousNumAffected": 0, "seriousNumAtRisk": 46, "otherNumAffected": 0, "otherNumAtRisk": 46}, {"id": "EG001", "title": "Placebo", "description": "Placebo plus standard care\n\nalbuterol: 2.5mg/dose by nebulizer, 7 doses over 6 hours\n\nIpratropium bromide: 2.5 mg, one dose\n\nPrednisone: 60mg PO", "seriousNumAffected": 0, "seriousNumAtRisk": 49, "otherNumAffected": 0, "otherNumAtRisk": 49}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": true}, "pointOfContact": {"title": "Dr. Robert Silverman", "organization": "North Shore Long Island Jewish Health System", "email": "rsilverman@nshs.edu", "phone": "718-470-7501"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}, {"id": "D000004630", "term": "Emergencies"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}, {"id": "D000020969", "term": "Disease Attributes"}, {"id": "D000010335", "term": "Pathologic Processes"}], "browseLeaves": [{"id": "M7796", "name": "Emergencies", "asFound": "Emergency", "relevance": "HIGH"}, {"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}, {"id": "M22700", "name": "Disease Attributes", "relevance": "LOW"}, {"id": "T170", "name": "Acute Graft Versus Host Disease", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "Rare", "name": "Rare Diseases"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000011241", "term": "Prednisone"}, {"id": "D000019819", "term": "Budesonide"}, {"id": "D000001965", "term": "Bromides"}, {"id": "D000000420", "term": "Albuterol"}, {"id": "D000009241", "term": "Ipratropium"}], "ancestors": [{"id": "D000000893", "term": "Anti-Inflammatory Agents"}, {"id": "D000005938", "term": "Glucocorticoids"}, {"id": "D000006728", "term": "Hormones"}, {"id": "D000006730", "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000018931", "term": "Antineoplastic Agents, Hormonal"}, {"id": "D000000970", "term": "Antineoplastic Agents"}, {"id": "D000001993", "term": "Bronchodilator Agents"}, {"id": "D000001337", "term": "Autonomic Agents"}, {"id": "D000018373", "term": "Peripheral Nervous System Agents"}, {"id": "D000018927", "term": "Anti-Asthmatic Agents"}, {"id": "D000019141", "term": "Respiratory System Agents"}, {"id": "D000000927", "term": "Anticonvulsants"}, {"id": "D000015149", "term": "Tocolytic Agents"}, {"id": "D000012102", "term": "Reproductive Control Agents"}, {"id": "D000058666", "term": "Adrenergic beta-2 Receptor Agonists"}, {"id": "D000000318", "term": "Adrenergic beta-Agonists"}, {"id": "D000000322", "term": "Adrenergic Agonists"}, {"id": "D000018663", "term": "Adrenergic Agents"}, {"id": "D000018377", "term": "Neurotransmitter Agents"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}, {"id": "D000018680", "term": "Cholinergic Antagonists"}, {"id": "D000018678", "term": "Cholinergic Agents"}], "browseLeaves": [{"id": "M21711", "name": "Budesonide", "asFound": "Of 1", "relevance": "HIGH"}, {"id": "M3767", "name": "Albuterol", "asFound": "Diameter", "relevance": "HIGH"}, {"id": "M14121", "name": "Prednisone", "asFound": "Min", "relevance": "HIGH"}, {"id": "M5241", "name": "Bromides", "asFound": "Root", "relevance": "HIGH"}, {"id": "M12193", "name": "Ipratropium", "asFound": "Levonorgestrel", "relevance": "HIGH"}, {"id": "M19560", "name": "Procaterol", "relevance": "LOW"}, {"id": "M4217", "name": "Anti-Inflammatory Agents", "relevance": "LOW"}, {"id": "M9047", "name": "Glucocorticoids", "relevance": "LOW"}, {"id": "M9789", "name": "Hormones", "relevance": "LOW"}, {"id": "M9788", "name": "Hormone Antagonists", "relevance": "LOW"}, {"id": "M20966", "name": "Antineoplastic Agents, Hormonal", "relevance": "LOW"}, {"id": "M5269", "name": "Bronchodilator Agents", "relevance": "LOW"}, {"id": "M20963", "name": "Anti-Asthmatic Agents", "relevance": "LOW"}, {"id": "M21137", "name": "Respiratory System Agents", "relevance": "LOW"}, {"id": "M4246", "name": "Anticonvulsants", "relevance": "LOW"}, {"id": "M17869", "name": "Tocolytic Agents", "relevance": "LOW"}, {"id": "M20746", "name": "Adrenergic Agents", "relevance": "LOW"}, {"id": "M3670", "name": "Adrenergic beta-Agonists", "relevance": "LOW"}, {"id": "M3673", "name": "Adrenergic Agonists", "relevance": "LOW"}, {"id": "M20504", "name": "Neurotransmitter Agents", "relevance": "LOW"}, {"id": "M20760", "name": "Cholinergic Antagonists", "relevance": "LOW"}, {"id": "M20758", "name": "Cholinergic Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Infl", "name": "Anti-Inflammatory Agents"}, {"abbrev": "Resp", "name": "Respiratory System Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "Repr", "name": "Reproductive Control Agents"}, {"abbrev": "ANeo", "name": "Antineoplastic Agents"}, {"abbrev": "AntiConv", "name": "Anticonvulsants"}]}}, "hasResults": true}